NCT03866590View on ClinicalTrials.gov

Pyruvate Kinase Deficiency Epidemiological Study (PIECE)

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

January 13, 2020

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Pyruvate Kinase Deficiency
Trial Locations (1)

33024

Intervent Clinical Research Center, Pembroke Pines

All Listed Sponsors
lead

CENTOGENE GmbH Rostock

INDUSTRY

NCT03866590 - Pyruvate Kinase Deficiency Epidemiological Study (PIECE) | Biotech Hunter | Biotech Hunter